News

New portal website for the Mission on Adaptation to Climate Change

Published on | 1 month ago

Programmes
Climate, Energy, Mobility Missions

The EU Mission on Adaptation to Climate Change has launched a new portal. The new website offers essential information and practical tools designed to facilitate Europe's transition to a climate-resilient future. Key sections include ongoing mission projects that highlight funded initiatives providing practical solutions for climate adaptation, and knowledge hubs that present tools and guidance for informed adaptation planning. Additionally, the portal features a news section to keep users updated on mission developments. There is also a tab reserved specifically for the community involved in the mission.

If you want to explore the new portal, click here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1824 articles available search in articles 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.